Nanthini Jayabalan

Nanthini Jayabalan

Auto-generated profile, based on publicly available information

Nanthini Jayabalan

Translational Neuroscience Lab, UQ Centre for Clinical Research, the University of Queensland, Brisbane, Australia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2018 in Clinical Science
Verified
Journal Article
Closed access
PDF file
SNSoumyalekshmi Nair
Soumyalekshmi Nair
NJNanthini Jayabalan
Nanthini Jayabalan
DGDominic Guanzon
Dominic Guanzon
CHCarlos Andres Palma Henriquez
Carlos Andres Palma Henriquez
KSKatherin Scholz-Romero
Katherin Scholz-Romero
Carlos SalomonCarlos Salomon
Carlos Salomon
There is increasing evidence that miRNAs, which are enriched in nanovesicles called exosomes, are important regulators of gene expression. When compared with normal pregnancies, pregnancies with gestational diabetes mellitus (GDM) are associated with skeletal muscle insulin resistance as well as increased levels of circulating placental exosomes. Here we investigated whether placental exosomes in GDM carry a specific set of miRNAs associated with skeletal muscle insulin sensitivity. Exosomes were isolated from chorionic villous (CV) explants from both women with Normal Glucose Tolerant (NGT) and GDM pregnancies. Using miRNA sequencing, we identified a specific set of miRNAs selectively enriched with exosomes and compared with their cells of origin indicating a specific packaging of miRNAs into exosomes. Gene target and ontology analysis of miRNA differentially expressed in exosomes secreted in GDM compared with NGT are associated with pathways regulating cell migration and carbohydrate metabolism. We determined the expression of a selected set of miRNAs in placenta, plasma, and skeletal muscle biopsies from NGT and GDM. Interestingly, the expression of these miRNAs varied in a consistent pattern in the placenta, in circulating exosomes, and in skeletal muscle in GDM. Placental exosomes from GDM pregnancies decreased insulin-stimulated migration and glucose uptake in primary skeletal muscle cells obtained from patients with normal insulin sensitivity. Interestingly, placental exosomes from NGT increase migration and glucose uptake in response to insulin in skeletal muscle from diabetic subjects. These findings suggest that placental exosomes might have a role in the changes on insulin sensitivity in normal and GDM pregnancies.

1 October 2019 in Journal of Molecular Endocrinology
Verified
Journal Article
Closed access
CNCaitlyn Nguyen-Ngo
Caitlyn Nguyen-Ngo
NJNanthini Jayabalan
Nanthini Jayabalan
CSCarlos Salomon
Carlos Salomon
MLMartha Lappas
Martha Lappas
Gestational diabetes mellitus (GDM) imposes serious short- and long-term health problems for mother and baby. An effective therapeutic that can reduce the incidence of GDM and improve long-term maternal and fetal outcomes is a major research priority, crucially important for public health. A lack of knowledge about the underlying pathophysiology of GDM has hampered the development of such therapeutics. What we do know, however, is that maternal insulin resistance, low-grade inflammation and endothelial cell dysfunction are three central features of pregnancies complicated by GDM. Indeed, data generated over the past decade have implicated a number of candidate regulators of insulin resistance, inflammation and endothelial cell dysfunction in placenta, maternal adipose tissue and skeletal muscle. These include nuclear factor-κB (NF-κB), peroxisome proliferator-activated receptors (PPARs), sirtuins (SIRTs), 5′ AMP-activated protein kinase (AMPK), glycogen synthase kinase 3 (GSK3), PI3K/mTOR, inflammasome and endoplasmic reticulum (ER) stress. In this review, the identification of these as key modulators of GDM will be discussed. The biochemical pathways involved in the formation of these may represent potential sites for intervention that may translate to therapeutic interventions to prevent the development of GDM.

1 June 2017 in Placenta
Verified
Journal Article
Closed access
SAStefanie Adam
Stefanie Adam
OEOmar Elfeky
Omar Elfeky
VKVyjayanthi Kinhal
Vyjayanthi Kinhal
SDSuchismita Dutta
Suchismita Dutta
ALAndrew Lai
Andrew Lai
Carlos SalomonCarlos Salomon
Carlos Salomon

27 September 2017 in Frontiers in Endocrinology
Verified
Journal Article
Open access
NJNanthini Jayabalan
Nanthini Jayabalan
SNSoumyalekshmi Nair
Soumyalekshmi Nair
ZNZarin Nuzhat
Zarin Nuzhat
GRGregory E. Rice
Gregory E. Rice
Felipe A. ZúñigaFelipe A. Zúñiga
Felipe A. Zúñiga
Carlos SalomonCarlos Salomon
Carlos Salomon
Obesity is an important public health issue worldwide, where it is commonly associated with the development of metabolic disorders, especially insulin resistance (IR). Maternal obesity is associated with an increased risk of pregnancy complications, especially gestational diabetes mellitus (GDM). Metabolism is a vital process for energy production and the maintenance of essential cellular functions. Excess energy storage is predominantly regulated by the adipose tissue. Primarily made up of adipocytes, adipose tissue acts as the body’s major energy reservoir. The role of adipose tissue, however, is not restricted to a ‘bag of fat’. The adipose tissue is an endocrine organ, secreting various adipokines, enzymes, growth factors and hormones that take part in glucose and lipid metabolism. In obesity, the greater portion of the adipose tissue comprises fat, and there is increased pro-inflammatory cytokine secretion, macrophage infiltration and reduced insulin sensitivity. Obesity contributes to systemic IR and its associated metabolic complications. Similar to adipose tissue, the placenta is also an endocrine organ. During pregnancy, the placenta secretes various molecules to maintain pregnancy physiology. In addition, the placenta plays an important role in metabolism and exchange of nutrients between mother and fetus. Inflammation at the placenta may contribute to the severity of maternal IR and her likelihood of developing GDM and may also mediate the adverse consequences of obesity and GDM on the fetus. Interestingly, studies on maternal insulin sensitivity and secretion of placental hormones have not shown a positive correlation between these phenomena. Recently, a great interest in the field of extracellular vesicles (EVs) has been observed in the literature. EVs are produced by a wide range of cells and are present in all biological fluids. EVs are involved in cell-to-cell communication. Recent evidence points to an association between adipose tissue-derived EVs and metabolic syndrome in obesity. In this review, we will discuss the changes in human placenta and adipose tissue in GDM and obesity and summarise the findings regarding the role of adipose tissue and placenta-derived EVs, with an emphasis on exosomes in obesity, and the contribution of obesity to the development of GDM.

3 December 2018 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
NJNanthini Jayabalan
Nanthini Jayabalan
ALAndrew Lai
Andrew Lai
VOValeska Ormazabal
Valeska Ormazabal
SAStefanie Adam
Stefanie Adam
DGDominic Guanzon
Dominic Guanzon
Carlos SalomonCarlos Salomon
Carlos Salomon
Context Molecules produced by adipose tissue (AT) function as an endocrine link between maternal AT and fetal growth by regulating placental function in normal and gestational diabetes mellitus (GDM). Objective We hypothesised that AT-derived exosomes from women with GDM carry a specific set of proteins that influences glucose metabolism in placenta. Design Exosomes were isolated from omental AT-conditioned media from pregnant women with normal glucose tolerance (exo-NGT, n=65) and women with GDM (exo-GDM, n=82). SWATH mass spectrometry (MS) was used to construct a small ion library from AT and exosomal proteins followed by ingenuity pathway analysis (IPA) to determine canonical pathways and biofunctions. The effect of exosomes on human placental cells was determined using a Human Glucose Metabolism RT2 Profiler PCR Array. Results The number of exosomes (vesicles/μg-tissue/24h) was significantly (1.7-fold) higher in GDM compared to NGT, and the number of exosomes positively correlated with birthweight Z score. IPA of the exosomal proteins revealed differential expression of the proteins targeting sirtuin (sirt) signalling pathway, oxidative phosphorylation (OXPHOS) and mechanistic target of rapamycin (mTOR) signalling pathways in GDM compared to NGT. Exo-GDM increased the expression of genes associated with glycolysis and gluconeogenesis in placental cells compared to the effect of exo-NGT. Conclusions Our findings are consistent with the possibility that AT exosomes play an important role in mediating the changes in placental function in GDM, which may be responsible for some of the adverse consequences in this pregnancy complication, such as fetal overgrowth.

7 December 2018 in Proteomics
Verified
Journal Article
Closed access
PDF file
NJNanthini Jayabalan
Nanthini Jayabalan
ALAndrew Lai
Andrew Lai
SNSoumyalekshmi Nair
Soumyalekshmi Nair
DGDominic Guanzon
Dominic Guanzon
KSKatherin Scholz‐Romero
Katherin Scholz‐Romero
Carlos SalomonCarlos Salomon
Carlos Salomon